skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Method for preparing radionuclide-labeled chelating agent-ligand complexes

Abstract

Radionuclide-labeled chelating agent-ligand complexes that are useful in medical diagnosis or therapy are prepared by reacting a radionuclide, such as .sup.90 Y or .sup.111 In, with a polyfunctional chelating agent to form a radionuclide chelate that is electrically neutral; purifying the chelate by anion exchange chromatography; and reacting the purified chelate with a targeting molecule, such as a monoclonal antibody, to form the complex.

Inventors:
 [1];  [1];  [2]
  1. Davis, CA
  2. El Macero, CA
Publication Date:
Research Org.:
Univ. of California (United States)
OSTI Identifier:
872538
Patent Number(s):
US 5958374
Assignee:
Regents of University of California (Oakland, CA)
DOE Contract Number:  
FG03-84ER60233
Resource Type:
Patent
Country of Publication:
United States
Language:
English
Subject:
method; preparing; radionuclide-labeled; chelating; agent-ligand; complexes; useful; medical; diagnosis; therapy; prepared; reacting; radionuclide; 90; 111; polyfunctional; agent; form; chelate; electrically; neutral; purifying; anion; exchange; chromatography; purified; targeting; molecule; monoclonal; antibody; complex; monoclonal antibody; anion exchange; chelating agent; radionuclide-labeled chelating; chelating agent-ligand; medical diagnosis; exchange chromatography; agent-ligand complexes; ligand complex; /424/999/

Citation Formats

Meares, Claude F, Li, Min, and DeNardo, Sally J. Method for preparing radionuclide-labeled chelating agent-ligand complexes. United States: N. p., 1999. Web.
Meares, Claude F, Li, Min, & DeNardo, Sally J. Method for preparing radionuclide-labeled chelating agent-ligand complexes. United States.
Meares, Claude F, Li, Min, and DeNardo, Sally J. Fri . "Method for preparing radionuclide-labeled chelating agent-ligand complexes". United States. https://www.osti.gov/servlets/purl/872538.
@article{osti_872538,
title = {Method for preparing radionuclide-labeled chelating agent-ligand complexes},
author = {Meares, Claude F and Li, Min and DeNardo, Sally J},
abstractNote = {Radionuclide-labeled chelating agent-ligand complexes that are useful in medical diagnosis or therapy are prepared by reacting a radionuclide, such as .sup.90 Y or .sup.111 In, with a polyfunctional chelating agent to form a radionuclide chelate that is electrically neutral; purifying the chelate by anion exchange chromatography; and reacting the purified chelate with a targeting molecule, such as a monoclonal antibody, to form the complex.},
doi = {},
url = {https://www.osti.gov/biblio/872538}, journal = {},
number = ,
volume = ,
place = {United States},
year = {1999},
month = {1}
}

Patent:

Save / Share:

Works referenced in this record:

Specific and stable labeling of antibodies with technetium-99m with a diamide dithiolate chelating agent.
journal, June 1988


Immunochemical aspects of monoclonal antibodies important for radiopharmaceutical development
journal, January 1986

  • DeNardo, Sally J.; Peng, Jo-Sen B.; DeNardo, Gerald L.
  • International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, Vol. 13, Issue 4
  • https://doi.org/10.1016/0883-2897(86)90002-4

Newer approaches to the radiolabeling of monoclonal antibodies by use of metal chelates
journal, January 1991


The production of 99mTc-labeled conjugated antibodies using a cyclam-based bifunctional chelating agent
journal, January 1987


Kinetics of interaction of metal ions with two tetraazatetraacetate macrocycles
journal, September 1982


Technetium labeling of monoclonal antibodies with functionalized BATOs. 1. TcCl(DMG)3PITC [phenyl isothiocyanate].
journal, May 1991


Copper chelates as probes of biological systems: Stable copper complexes with a macrocyclic bifunctional chelating agent
journal, July 1985


Chimeric L6 anti-tumor antibody. Genomic construction, expression, and characterization of the antigen binding site.
journal, August 1992


Tumour targeting with radiolabelled macrocycle–antibody conjugates
journal, January 1990